ECS Botanics Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

ECS Botanics Holdings şirketinin toplam hissedar öz sermayesi A$28.2M ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$32.9M ve A$4.7M dir. ECS Botanics Holdings 'in FAVÖK'ü A$1.9M faiz karşılama oranı 70.8 dur. Şirketin A$3.2M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	70.8x
Nakit	AU$3.16m
Eşitlik	AU$28.21m
Toplam yükümlülükler	AU$4.67m
Toplam varlıklar	AU$32.88m

Son finansal sağlık güncellemeleri

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Feb 24

Recent updates

Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop

Nov 11

There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise

Sep 27

ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business

Aug 12

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

Apr 03

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Sep 06

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Feb 24

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: ECS 'nin kısa vadeli varlıkları ( A$19.7M ) kısa vadeli yükümlülüklerini ( A$3.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: ECS şirketinin kısa vadeli varlıkları ( A$19.7M ) uzun vadeli yükümlülüklerini ( A$785.2K ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: ECS borçsuzdur.

Borcun Azaltılması: ECS şirketinin 5 yıl önce borç/öz sermaye oranı 1.3% iken borcu yok.

Borç Kapsamı: ECS un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: ECS şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

ECS Botanics Holdings Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

Recent updates

Lacklustre Performance Is Driving ECS Botanics Holdings Ltd's (ASX:ECS) 26% Price Drop

ECS Botanics Holdings Ltd, Annual General Meeting, Nov 21, 2024

There's No Escaping ECS Botanics Holdings Ltd's (ASX:ECS) Muted Earnings Despite A 38% Share Price Rise

ECS Botanics Holdings Ltd Announces Management Appointments

Full year 2024 earnings released: EPS: AU$0.002 (vs AU$0 in FY 2023)

New minor risk - Share price stability

ECS Botanics Holdings Ltd's (ASX:ECS) Shares Lagging The Market But So Is The Business

There Is A Reason ECS Botanics Holdings Ltd's (ASX:ECS) Price Is Undemanding

New minor risk - Profit margin trend

New minor risk - Shareholder dilution

First half 2024 earnings released: EPS: AU$0.001 (vs AU$0.001 loss in 1H 2023)

ECS Botanics Holdings Ltd to Report Q2, 2024 Results on Feb 28, 2024

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 4.000016 million.

ECS Botanics Holdings Ltd's (ASX:ECS) Share Price Could Signal Some Risk

Full year 2023 earnings released: EPS: AU$0 (vs AU$0.001 loss in FY 2022)

New minor risk - Financial data availability

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2023

ECS Botanics Holdings Ltd Launches Investor Hub

First half 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in 1H 2022)

ECS Botanics Holdings Ltd Announces Resignation of Mr. Alex Keach as Head of Corporate Development and an Executive Director

No independent directors

Blue Buffalo Pty Ltd has entered into a binding share purchase agreement to acquire ECS Botanics Pty Ltd from ECS Botanics Holdings Ltd (ASX:ECS) for AUD 3 million.

Full year 2022 earnings released: AU$0.001 loss per share (vs AU$0.006 loss in FY 2021)

ECS Botanics Holdings Ltd, Annual General Meeting, Oct 26, 2022

MD & Executive Director recently bought AU$90k worth of stock

ECS Botanics Holdings Ltd Announces Change of Managing Director

ECS Botanics Holdings Ltd Announces Executive Changes

No independent directors

Founder exercised options to buy AU$510k worth of stock.

Full year 2021 earnings released: AU$0.006 loss per share (vs AU$0.009 loss in FY 2020)

ECS Botanics Holdings Ltd Launches Innovative range of 30ml Terpene Blends

ECS Botanics Holdings Ltd Appoints Nan Maree Schoerie as Director

ECS Botanics Holdings (ASX:ECS) Is In A Good Position To Deliver On Growth Plans

First half 2021 earnings released: AU$0.005 loss per share (vs AU$0.008 loss in 1H 2020)

ECS Botanics Holdings Ltd Appoints Paul Hanrahan as Site & Cultivation Manager

ECS Botanics Holdings Ltd (ASX:ECS) signed a binding term sheet to acquire Murray Meds Pty Ltd, Flowerday Farms Pty Ltd and Flowerday Land Property from Flowerday Holdings Pty Ltd for AUD 7.5 million.

ECS Botanics Holdings Ltd Enters into Term Sheet with Medipharm Labs

ECS Botanics Holdings Ltd announced that it expects to receive AUD 4 million in funding

ECS Provides Medicinal Cannabis Project and Regulatory Update

ECS Botanics Holdings Ltd Appoints Damian Wood as Director of Medicinal Cannabis Production

ECS Botanics Holdings Ltd has completed a Follow-on Equity Offering in the amount of AUD 0.75 million.

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin